Project Grant K99AI185151

Award Date 6/11/24
Completion Date 5/31/26
Dollars Obligated $125K
Federal Grant Program
93.855
Assistance Type
Project Grant
Place of Performance
Massachusetts, USA
Similar Awards
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $211,038 to The Johns Hopkins University to research a new strategy for controlling mosquito populations. The project aims to investigate the role of the enzyme iodotyrosine deiodinase in mosquitoes, specifically examining how inhibiting this enzyme or accumulating certain halotyrosines can impact mosquito fertility...
This Cooperative Agreement award from the National Institute of Allergy and Infectious Diseases (NIAID), under CFDA Program 93.855 Allergy and Infectious Diseases Research, provides $606,815.00 in funding to Duquesne University to advance paratransgenesis research for malaria control. The goal is to engineer bacterial strains of Asaia bogorensis that can interfere with the ability of mosquitoes to transmit malaria parasites. The project aims to create paratransgenic strains that are field-ready,...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides a total of $699,814 to Florida International University to study the molecular mechanisms of Plasmodium parasite-Anopheles mosquito midgut interactions and evaluate candidate proteins as novel targets for malaria transmission-blocking vaccines. The key objectives are to functionally characterize mosquito and parasite...
This $400,000 Project Grant from the National Science Foundation (NSF) Integrative Activities (IA) program will fund research at Auburn University to investigate the mechanisms of Wolbachia-induced cytoplasmic incompatibility in insects. The project aims to delineate the molecular targets and evolutionary origins of this reproductive manipulation by endosymbiotic bacteria, with the goal of developing novel, environmentally-friendly biocontrol strategies to manage insect pests. The research...
This Project Grant award of $651,084, made by the National Science Foundation (NSF) Biological Sciences program (CFDA 47.074), supports research to determine how microbes influence the response of their mosquito host to climate change, with a focus on the impacts on Hawaiian honeycreepers, an endangered bird species. The research aims to: Clarify the landscape-scale population dynamics of the mosquito vector Culex quinquefasciatus and its microbiome across an elevational gradient in Hawaii....
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $429,000.00 to The Medical College of Wisconsin, Inc. over a period from June 25, 2025 to May 31, 2027. The project aims to: 1) Map chromatin architecture during immune activation in mosquito hemocyte cells, and 2) Identify gene regulatory networks for the immune deficiency (IMD) pathway genes by modulating enhancer...
This Project Grant award, funded by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), aims to discover the targets of naturally acquired protection against severe Plasmodium falciparum malaria and develop them as novel blood-stage vaccine candidates. The award, totaling $708,202 and effective from December 2024 through November 2029, will support research at Brown University to identify the parasite...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $648,924 to Iowa State University of Science and Technology to conduct research on the role of mosquito extracellular vesicles in malaria parasite killing and immune priming. The 5-year project, running from February 2025 to January 2030, aims to obtain a mechanistic understanding of how extracellular vesicles...
This two-year $138,000 Project Grant from the National Science Foundation's Biological Sciences program (CFDA 47.074) will fund postdoctoral research characterizing the role of Wolbachia in an insect vector-virus pathosystem. The grant recipient will conduct research at Athens, Georgia from September 2021 through August 2023 to further the program's goals of strengthening the nation's biological sciences enterprise and increasing scientific knowledge of major problems. Funding will support the...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $832,071 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to Seattle Children's Hospital, doing business as Seattle Children's Research Institute, to develop a universal transmission blocking vaccine against malaria. The goal is to create a vaccine targeting conserved mosquito-stage antigens that can prevent infection across multiple Plasmodium species that cause malaria. Key aspects...

HARNESSING WOLBACHIA-INDUCED CONDITIONAL INFERTILITY FOR CONTROL OF THE MALARIA MOSQUITO - PROJECT SUMMARY: WOLBACHIA ENDOSYMBIONTS HOLD STRONG POTENTIAL FOR THE CONTROL OF VECTOR-BORNE INFECTIONS. INDEED, THESE BACTERIA ARE CURRENTLY USED TO CONTROL DENGUE VIRUS TRANSMISSION BY AEDES AEGYPTI, WHERE THEY COMBINE THE ABILITY TO SPREAD THROUGH POPULATIONS VIA CYTOPLASMIC INCOMPATIBILITY (CI) WITH EFFICIENT BLOCKING OF ARBOVIRAL INFECTIONS. FOR DECADES, HOWEVER, SCIENTISTS HAVE BEEN PUZZLED BY THE APPARENT LACK OF BOTH NATURAL AND ARTIFICIAL WOLBACHIA INFECTIONS IN ANOPHELES, THE VECTORS OF HUMAN MALARIA, WITH ONLY A HANDFUL OF EXAMPLES REPORTED. WOLBACHIA ARE GENETICALLY INTRACTABLE, MAKING FUNCTIONAL STUDY OF BOTH THEIR REPRODUCTIVE MANIPULATIONS AND THIS HOST TROPISM DIFFICULT. HOWEVER, MY PREVIOUS WORK SUGGESTS THAT A WOLBACHIA-DERIVED CI-INDUCING FACTOR, CIFB, CAUSES SEVERE ABNORMALITIES IN FEMALES (RESCUED BY A DIFFERENT GENE, CIFA), THAT MAY IN PART PREVENT WOLBACHIA FROM ESTABLISHING NATURAL INFECTIONS IN ANOPHELES MOSQUITOES. I WILL ELUCIDATE THE MECHANISMS REGULATING WOLBACHIA INFECTIONS IN ANOPHELES, WHILE GAINING GENERAL MECHANISTIC INSIGHT INTO CI IN INSECTS. USING A COMBINATION OF GENETICS, CELL BIOLOGY, MOLECULAR, GENOMIC AND BIOINFORMATICS APPROACHES TO ADDRESS KEY QUESTIONS RELATED TO WOLBACHIA TOXICITY AND RESCUE ACROSS DIFFERENT INSECTS, THESE STUDIES WILL PUSH THE FIELD OF INSECT-ENDOSYMBIONT INTERACTIONS INTO NEW AREAS OF INQUIRY AND WILL ALSO GENERATE TOOLS FOR THE GENERATION OF WOLBACHIA-BASED STRATEGIES FOR THE CONTROL OF MALARIA-TRANSMITTING ANOPHELES POPULATIONS. I WILL CONDUCT THE K99 PHASE OF THIS AWARD AS A POST-DOCTORAL RESEARCHER IN DR. FLAMINIA CATTERUCCIA'S GROUP AT THE HARVARD T.H. CHAN SCHOOL OF PUBLIC HEALTH. THE LABORATORY IS EXCEPTIONALLY WELL-EQUIPPED TO ESTABLISH TRANSGENIC INSECTS AND IS ONE OF THE ONLY VECTOR BIOLOGY LABS WITH A ROBOTIC MICRO-INJECTOR AND A COPAS BIOSORTER IN ADDITION TO A WORLD-CLASS PLASMODIUM INFECTION FACILITY. DR. CATTERUCCIA IS SUPPORTED BY THE HOWARD HUGHES MEDICAL INSTITUTE, WHICH ALLOWS FLEXIBILITY OF RESEARCH FUNDS WHICH CAN BE DRAWN UPON FOR THIS PROJECT, AND FACILITATES ACCESS TO STATE-OF-THE-ART EQUIPMENT, FACILITATING EXPANSIVE RESEARCH IN VECTOR BIOLOGY. IN ADDITION TO DR. CATTERUCCIA'S EXPERTISE IN MOSQUITO REPRODUCTION, MOSQUITO TRANSGENESIS, AND HOST-PARASITE INTERACTIONS, I WILL BE SUPPORTED BY DR. ZHIYONG XI, AN EXPERT AT THE FOREFRONT OF WOLBACHIA-BASED VECTOR CONTROL IMPLEMENTATION IN AEDES MOSQUITOES, AND IN ESTABLISHING WOLBACHIA INFECTIONS IN ANOPHELES. FURTHER, I WILL COLLABORATE WITH DR. JOHN BECKMANN, A MOLECULAR BIOLOGIST AND BIOCHEMIST WITH EXPERTISE WORKING WITH WOLBACHIA'S CI-INDUCING FACTORS, AND DR. LAUREN CHILDS, A MATHEMATICAL MODELING SPECIALIST. ADDITIONAL MENTORS WILL INCLUDE LOCAL RESEARCHERS DR. DANIEL NEAFSEY, WHO HAS VAST EXPERIENCE WITH FUNCTIONAL GENOMICS IN WOLBACHIA, ANOPHELES, AND PLASMODIUM, AND DR. PAUL GARRITY WHOSE GROUP EXCELS AT GENETIC ENGINEERING OF VARIOUS DIPTERANS. THIS COMBINATION OF EXPERTISE WILL TRAIN ME TO HAVE A UNIQUE PERSPECTIVE AND SKILLSET TO APPLY TO RESEARCH QUESTIONS RELATED TO TRIPARTITE INTERACTIONS BETWEEN WOLBACHIA, ANOPHELES AND PLASMODIUM, WITH WHICH I WILL BE WELL- POSITIONED TO ESTABLISH AN INDEPENDENT LABORATORY WITH A DISTINCT SET OF RESEARCH CAPABILITIES AND QUESTIONS.

Posted 6/11/24, 12:00 AM